Protocolo de tratamiento de la bacteriemia asociada a catéter vascular central de larga duración

  1. Carmona-Torre, F.
  2. Yuste, J.R.
  3. del Pozo, J.L.
Aldizkaria:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Argitalpen urtea: 2018

Zenbakien izenburua: Enfermedades infecciosas (II): Infecciones por bacilos Gram negativos

Saila: 12

Zenbakia: 50

Orrialdeak: 2972-2976

Mota: Artikulua

DOI: 10.1016/J.MED.2018.02.014 DIALNET GOOGLE SCHOLAR

Beste argitalpen batzuk: Medicine: Programa de Formación Médica Continuada Acreditado

Laburpena

Introduction Long-term central vascular catheter-related bacteraemia (LTCVCB) is the most common cause of early catheter withdrawal, resulting in high morbidity, mortality and increased consumption of healthcare costs. Treatment Treatment depends on the clinical characteristics and the pathogens responsible for the infection, ranging from removal of the infected catheter to conservative treatment with combined systemic antibiotic and antibiotic lock therapy.

Erreferentzia bibliografikoak

  • Bustos C, Aguinaga A, Carmona-Torre F, del Pozo JL. Long term catheterization: current approaches in the diagnosis and treatment of port related infections. Infect Drug Resist. 2014;7:25-35.
  • Zakhour R, Chaftari A-M, Raad II. Catheter-related infections in patients with haematological malignancies: novel preventive and therapeutic strategies. Lancet Infect Dis. 2016;16(11):e241-e50.
  • Lebeaux D, Fernández-Hidalgo N, Chauhan A, Lee S, Ghigo JM, Almirante B. Management of infections related to totally implantable venous access ports: challenges and perspectives. Lancet Infect Dis. 2014;14(2):146-59.
  • Rodríguez-Bano J. Selection of empiric therapy in patients with catheter related infections. Clin Microbiol Infect. 2002;8(5):275-81.
  • Mermel Leonard A, Allon M, Bouza E, Craven Donald E, Flynn P, O’Grady Naomi P. Clinical practice guidelines for the diagnosis and management of intravascular catheter related infection: 2009 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases. 2009;49(1):1-45.
  • Raad I, Davis S, Khan A, Tarrand J, Elting L, Bodey GP. Impact of central venous catheter removal on the recurrence of catheter related coagulase negative staphylococcal bacteremia. Infect Control Hosp Epidemiol. 1992;13(4):215-21.
  • Marcos M, Soriano A, Inurrieta A, Martínez JA, Romero A, Cobos N. Changing epidemiology of central venous catheter-related bloods tream infections: increasing prevalence of Gram negative pathogens. J Antimicrob Chemother. 2011;66(9):2119-25.
  • Mensa J, Soriano A, Llinares P, Barberan J, Montejo M, Salavert M. [Guidelines for antimicrobial treatment of the infection by Staphylococcus aureus]. Rev Esp Quimioter. 2013;26 Suppl 1:1-84.
  • Raad I, Darouiche R, Vázquez J, Lentnek A, Hachem R, Hanna H. Efficacy and Safety of weekly dalbavancin therapy for catheter related bloodstream infection caused by gram-positive pathogens. Clinical Infectious Diseases. 2005;40(3):374-80.
  • Walraven CJ, Lee SA. Antifungal lock therapy. Antimicrob Agents Chemother. 2013;57(1):1-8.
Datuen iturria: Dialnet